Don’t treat with radioiodine low-risk differentiated thyroid carcinomas (namely “microcarcinomas” or carcinomas <1 cm, in the absence of unfavorable prognostic factors), after total thyroidectomy
Both the literature and the guidelines of the American Thyroid Association and the European Association of Nuclear Medicine (EANM) agree on this position. However, established clinical practice does not correspond to this “official” position, and, in many cases,...
Don’t perform lymphoscintigraphy and radioguided biopsy of the sentinel node in patients affected by cutaneous melanoma thinner than 0.75 mm, with no ulceration and mitotic rate <1/mm2
The treatment of choice for these patients is adequate surgical removal alone of the primitive tumour. Given the optimal prognosis (97% survival at 10 years), radioguided biopsy of the sentinel node would imply useless exposure to ionizing radiations, as well as...
Don’t perform PET/CT with [18F]FDG (Fluorodeoxyglucose) in suspected peripheral osteomyelitis and in differential diagnosing between acute and chronic infection.
Since [18F] FDG-PET/CT showed high sensibility in the diagnosis of spondylitis and spondylodiscitis, some Nuclear Medicine physicians may substitute scintigraphy with labelled white blood cell with this technique in every infectious disease. Labelled white blood cell...
Don’t use brain SPECT (Single photon emission computed tomography) with DAT (dopamine transporter) radiopharmaceuticals in the differential diagnosis of degenerative Parkinsonisms or to convince a patient with Parkinson’s disease that he/she is really affected with that disease.
Although some papers in the literature have shown mild to moderate striatal uptake differences between the several forms of degenerative Parkinsonisms at group level, there is a considerable overlap at individual level and thus it is very unlikely that brain SPECT...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments